Skip to main content
Clinical Trials/CTRI/2023/06/053779
CTRI/2023/06/053779Not yet recruitingPhase 4

Study of effectiveness of Ketamine versus ECT as adjunctive therapy in severe depressive episodes with suicidal ideation in a tertiary care hospital in Odisha

avanya Seth0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients giving written informed consent or their representatives if the patients are too unwell to provide consent at the time of recruitment. HAM-D score more than or equal to 19. SSI score more than or equal to 4.

Exclusion Criteria

  • -Individuals diagnosed with dementia and/or mental retardation
  • -Individuals diagnosed with seizure disorder or severe head injury, severe medical/surgical illness or electrocardiogram abnormality
  • -Individuals having a history of schizophrenia or other psychotic disorders.
  • -Individuals diagnosed with Depression with psychotic features
  • -Individuals having a history of contraindications for ketamine or a history of ketamine abuse/dependence.(eg. Severe cardiovascular disease, elevated intra cranial pressure, severe liver disease, poorly controlled HTN)
  • -History of alcohol or substance dependence (except nicotine and caffeine) in the year prior to the study
  • -Women who are pregnant or breastfeeding.

Investigators

Sponsor
avanya Seth

Similar Trials